These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1503305)

  • 1. [Antitoxin accident during botulism].
    Chaussinand JP; Loyer JJ; Paulin P
    Ann Fr Anesth Reanim; 1992; 11(2):241-2. PubMed ID: 1503305
    [No Abstract]   [Full Text] [Related]  

  • 2. [Specific antitoxic therapy of botulism].
    Nikiforov VN; Nikiforov VV; Glukhikh OA; Tashpulatov ShA
    Sov Med; 1985; (10):46-50. PubMed ID: 3909448
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lesions of the peripheral nervous system following administration of antibotulinic serum].
    Bateĭko VIa; Tomashpol'skiĭ IV; Gavura VV
    Vrach Delo; 1976 Aug; (8):144-5. PubMed ID: 190800
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)-(Equine) (BAT
    Parrera GS; Astacio H; Tunga P; Anderson DM; Hall CL; Richardson JS
    Toxins (Basel); 2021 Dec; 14(1):. PubMed ID: 35050996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Question 1: In infant botulism, is equine-derived botulinum antitoxin (EqBA) an effective alternative therapy to human-derived botulinum immune globulin (BIG)?
    Moneim J
    Arch Dis Child; 2018 Sep; 103(9):907-909. PubMed ID: 30007943
    [No Abstract]   [Full Text] [Related]  

  • 6. Antitoxin levels in botulism patients treated with trivalent equine botulism antitoxin to toxin types A, B, and E.
    Hatheway CH; Snyder JD; Seals JE; Edell TA; Lewis GE
    J Infect Dis; 1984 Sep; 150(3):407-12. PubMed ID: 6481185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equine antitoxin use and other factors that predict outcome in type A foodborne botulism.
    Tacket CO; Shandera WX; Mann JM; Hargrett NT; Blake PA
    Am J Med; 1984 May; 76(5):794-8. PubMed ID: 6720725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serotherapy of botulism].
    Nikiforov VN; Glukhikh OA; Nikiforov VV; Rezepov FF; Akhizova TIa
    Sov Med; 1986; (9):44-7. PubMed ID: 3798222
    [No Abstract]   [Full Text] [Related]  

  • 9. Foodborne botulism treated with heptavalent botulism antitoxin.
    Hill SE; Iqbal R; Cadiz CL; Le J
    Ann Pharmacother; 2013 Feb; 47(2):e12. PubMed ID: 23362041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulism and pregnancy.
    Polo JM; Martin J; Berciano J
    Lancet; 1996 Jul; 348(9021):195. PubMed ID: 8684170
    [No Abstract]   [Full Text] [Related]  

  • 11. Botulism immune plasma (human).
    Lewis GE; Metzger JF
    Lancet; 1978 Sep; 2(8090):634-5. PubMed ID: 80561
    [No Abstract]   [Full Text] [Related]  

  • 12. Development and evaluation of candidate vaccine and antitoxin against botulinum neurotoxin serotype F.
    Yu YZ; Zhang SM; Ma Y; Zhu HQ; Wang WB; Du Y; Zhou XW; Wang RL; Wang S; Yu WY; Huang PT; Sun ZW
    Clin Immunol; 2010 Nov; 137(2):271-80. PubMed ID: 20696619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulism.
    Sobel J
    Clin Infect Dis; 2005 Oct; 41(8):1167-73. PubMed ID: 16163636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equine botulinum antitoxin for the treatment of infant botulism.
    Vanella de Cuetos EE; Fernandez RA; Bianco MI; Sartori OJ; Piovano ML; Lúquez C; de Jong LI
    Clin Vaccine Immunol; 2011 Nov; 18(11):1845-9. PubMed ID: 21918119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective survey to evaluate the safety and efficacy of Japanese botulinum antitoxin therapy in Japan.
    Mottate K; Yokote H; Mori S; Horita A; Miyatsu Y; Torii Y; Kozaki S; Iwaki M; Takahashi M; Ginnaga A
    Toxicon; 2016 Feb; 110():12-8. PubMed ID: 26615088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myths and facts...about botulism.
    McConnell EA
    Nursing; 1998 Sep; 28(9):17. PubMed ID: 9775872
    [No Abstract]   [Full Text] [Related]  

  • 17. [Human anti-botulin immunoglobulin in botulism].
    Nikiforov VN; Nikiforov VV; Tashpulatov ShA; Al'bitskaia NB; Kuznetsova VI
    Sov Med; 1985; (2):63-6. PubMed ID: 3992329
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diagnostics and treatment of botulism].
    Kaakkola S
    Duodecim; 2001; 117(4):421-5; quiz 425, 441. PubMed ID: 12092386
    [No Abstract]   [Full Text] [Related]  

  • 19. [A clinical case of botulism].
    Smirnov DA; Groshev AD; Plashchevskiì AT; Shishkin VP
    Anesteziol Reanimatol; 1989; (1):53-4. PubMed ID: 2712393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cranial botulism.
    Luigetti M; Sabatelli M
    Neuromuscul Disord; 2012 Nov; 22(11):995-6. PubMed ID: 22727688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.